We describe a new, sensitive, rapid, and nonradioactive method involving the use of the commercially available BOCILLIN FL, a fluorescent penicillin, as a labeling reagent for the detection and study of penicillinbinding proteins (PBPs). This method allowed rapid detection of 30 ng of a purified PBP protein under UV light and of 2 to 4 ng of the protein with the aid of a FluorImager. This method also allowed rapid determination of the PBP profiles of Escherichia coli, Pseudomonas aeruginosa, and Streptococcus pneumoniae. The PBP profiles obtained are virtually identical to those reported previously with 3 H-, 14 C-, or 125 I-labeled penicillin. Using this method enabled us to determine the 50% inhibitory concentrations of the penicillinsensitive and -resistant PBP2x proteins of S. pneumoniae for penicillin G, thereby allowing a direct evaluation of their relative affinities for penicillin G. Finally, this method also allowed us to compare relative affinities of a PBP2x protein for different ␤-lactam antibiotics with the aid of fluorescence polarization technology and to monitor a PBP2x protein during purification.
Penicillin-binding proteins (PBPs) are the enzymes that are required for the biosynthesis of the bacterial cell wall (10, 11, 23, 31) . PBPs catalyze the final steps of the polymerization (transglycosylation) and cross-linking (transpeptidation) of peptidoglycan, an essential component of the bacterial cell wall (10, 11, 23, 31) . PBPs are membrane-bound enzymes and targets of ␤-lactam antibiotics (6, 7, 10, 11, 14, 24, (28) (29) (30) (31) . The emerging resistance of pathogenic gram-positive bacteria to ␤-lactam antibiotics is a serious clinical problem (6, 25, 29, 30) . Resistance to ␤-lactam antibiotics in some species such as Streptococcus pneumoniae has occurred by development of altered high-molecular-mass PBPs which have reduced affinity for the antibiotics (6, 7, 10, 11, 14, 24, 25, 29, 30) . Extensive molecular and genetic studies have been devoted to the understanding of the mechanisms of bacterial resistance to ␤-lactam antibiotics (6, 7, 10, 11, 25, 29, 30) .
PBPs have often been detected by labeling bacterial membrane preparations with 3 H-, 14 C-, or 125 I-labeled penicillin, separating the labeled proteins by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE), and exposing the gels to X-ray films (22, 27, 28) . The major limitations of this type of methodology are time intensiveness (days to weeks), accumulation of hazardous materials, and lack of commercial availability.
In this study, we describe a new, rapid, sensitive, and nonradioactive method for the detection and study of bacterial PBPs. This method involves the use of BOCILLIN FL (Fig. 1) , a newly synthesized and commercially available fluorescent penicillin, as a labeling reagent (Molecular Probes, Inc., Eugene, Oreg.). The BOCILLIN FL-labeled PBPs were separated by SDS-PAGE and detected with a FluorImager or with the naked eye under UV light. Fig. 1) , a derivative of penicillin V, is an orange solid with an extinction coefficient of 68,000 and a maximal absorption at 504 nm (Molecular Probes, Inc.). It fluoresces at 511 nm upon excitation at 504 nm (Molecular Probes, Inc.). BOCILLIN FL was stable for months with no apparent loss of its activity when it was stored at Ϫ20°C, even after repeated freezing and thawing (this study).
MATERIALS AND METHODS

Materials. BOCILLIN FL (
Cefaclor, cephalexin, penicillin V, and penicillin G were from Eli Lilly. Methicillin and cefotaxime were obtained from Sigma Chemical Company (St. Louis, Mo.). Imipenem was obtained from Merck, Sharp, and Dohme (Westpoint, Pa.). Piperacillin was obtained from Cyanamid (Wayne, N.J.).
Detection of PBPs from bacterial membrane preparations. For preparation of membranes for the detection of PBPs with BOCILLIN FL as a labeling reagent, the following bacterial strains were used: Escherichia coli MC6RP1 (F Ϫ thrA leuA proA dra drm lysA) (9) , Pseudomonas aeruginosa PAO1 (16), and S. pneumoniae (hex) R6, a penicillin-sensitive and uncapsulated derivative of Rockefeller University strain R36A that was kindly provided by A. Tomasz (Rockefeller University). E. coli and P. aeruginosa were first grown in Luria-Bertani (LB) medium (Difco Laboratories, Detroit, Mich.), with vigorous shaking, at 33°C overnight. The overnight cultures (10 ml each) were inoculated into 350 ml of fresh LB medium, allowed to grow to an optical density at 600 nm (OD 600 ) of 1.0, and harvested by centrifugation at 4,400 ϫ g for 8 min. Cells were washed once with 20 mM potassium phosphate (pH 7.5) and 140 mM NaCl, resuspended in the same buffer, and disrupted by passing through a French press cell (Aminco Laboratories, Inc., Rochester, N.Y.) twice at 20,000 lb/in 2 . The resulting cell lysates were centrifuged at 12,000 ϫ g for 10 min. The supernatant fractions were collected and centrifuged at 150,000 ϫ g for 35 min. The pellets were collected, washed once, and resuspended in the same phosphate buffer (1 ml each). The resulting suspensions were designated as membrane preparations and used for fluorescent BOCILLIN FL binding assays. The protein concentrations of the membrane preparations were determined by using the Bradford protein assay kit (1), with bovine serum albumin as a standard (Bio-Rad Laboratories, Hercules, Calif.).
S. pneumoniae (hex) R6 was grown in 500 ml of brain heart infusion medium (Difco), without shaking, at 37°C. Cells were collected at an OD 600 of 0.5 to 0.8, and membranes were prepared as described above.
For detection of the PBPs of E. coli, P. aeruginosa, and S. pneumoniae (hex) R6, reaction mixtures (100 l each) contained 75 l of each membrane preparation (Ϸ300 g of protein) and 25 l of various amounts of BOCILLIN FL ranging from 0.4 to 50 M (final concentration). The reaction mixtures were incubated at 35°C for 30 min and denatured with 100 l each of SDS-denaturing solution (19) at 100°C for 3 min. Then, 5 to 10 l of each reaction mixture (Ϸ7.5 to 15 g of protein) was subjected to SDS-PAGE analysis (10% polyacrylamide gel; Bio-Rad Laboratories) (19) . The protein gels were rinsed with water immediately after electrophoresis. To visualize the labeled PBPs, the gels were directly scanned with a FluorImager 575 (excitation at 488 nm and emission at 530 nm) (Molecular Dynamics, Inc., Sunnyvale, Calif.).
Sensitivity of BOCILLIN FL for detection of PBPs and IC 50 (50% inhibitory concentration) determinations. The penicillin-sensitive and -resistant PBP2x proteins from S. pneumoniae (hex) R6 (a penicillin-sensitive isolate) and 328 (a penicillin-resistant clinical isolate), respectively, were purified as described previously (33) . Protein concentrations were determined as described above (1) .
For assessment of the sensitivity of BOCILLIN FL for the detection of PBPs, reaction mixtures (10 l each) contained 2 to 48 ng of the purified penicillinsensitive PBP2x protein of S. pneumoniae, 10 M BOCILLIN FL, 20 mM potassium phosphate (pH 7.5), and 140 mM NaCl. The reaction mixtures were incubated at 35°C for 30 min, denatured with 10 l of SDS solution, and subjected to SDS-PAGE as described above. The labeled protein was visualized with a FluorImager as described above or with the naked eye under UV light (290 nm). For quantitation of the protein, the labeled protein was scanned with a FluorImager, and fluorescence intensities of each band were quantified with an Ultrascan XL laser densitometer (Pharmacia LKB Biotechnology, Alameda, Calif.).
For comparison with the 125 I-labeled penicillin V method, both penicillinsensitive and -resistant PBP2x proteins of S. pneumoniae were labeled with 125 I-labeled penicillin V and separated by SDS-PAGE as described previously (27, 33) . The resulting protein gels were dried and exposed to X-ray films as described previously (27, 33) .
For determination of IC 50 s of the two PBP2x proteins for penicillin G, reaction mixtures (20 l each) contained 25 mM potassium phosphate (pH 7.5), 3 g of each PBP2x protein, 10 M BOCILLIN FL, and various amounts of penicillin G. The reaction mixtures were incubated at 35°C for 15 min, denatured with 20 l of SDS solution, and subjected to SDS-PAGE as described above. Both PBP2x proteins were detected by using the FluorImager. Fluorescence intensities of each band were quantified by using an Ultrascan XL laser densitometer (Pharmacia LKB Biotechnology).
Fluorescence polarization. To determine IC 50 s of the penicillin-sensitive PBP2x protein for different ␤-lactam antibiotics, fluorescence polarization binding assays were performed in quadruplicate by using 96-well black opaque microplates (Costar, Cambridge, Mass.). All reagents were diluted in BGG buffer (100 mM potassium phosphate [pH 7.4], 100 g of bovine gamma globulin/ml; PanVera, Inc.) prior to use. In the standard assay, 50 l of BOCILLIN FL (final assay concentration, 2 nM) was added to the well, followed by 50 l of each ␤-lactam compound (final concentrations ranging from 0.01 to 10,000 nM) and 100 l of penicillin-sensitive PBP2x enzyme (final concentration, 1.3 nM). After shaking for 1 min, the plate was incubated at room temperature for 2 h. To determine maximum binding, buffer was used instead of added compound, and to determine the basal polarization associated with unbound BOCILLIN FL probe, buffer was substituted for the enzyme. Polarization measurements were made on a multimode Analyst instrument (LJL Biosystems, Inc., Sunnyvale, Calif.) equipped with excitation and emission filters of 485 and 520 nm, respectively, and a fluorescein-specific beamsplitter. The focusing optics were directed at a point in the well 4 mm above the bottom (z height) which minimizes the polarization effects from fluorophores that may be bound to the surfaces of the well. A dynamic polarization filter switches automatically to record intensity signals both vertically and horizontally. Intensities measured were corrected for background from the buffer-only condition.
Polarization (P) was calculated by using the following equation:
where P is polarization, a unit-dimensionless number representing the ratio of the light intensities, expressed in millipolarization (mP), I v is the fluorescence intensity measured when the excitation and emission polarizers are parallel, I h is the fluorescence intensity measured when the excitation and emission polarizers are perpendicular, and G is the grating factor that corrects for instrument bias which may be contributed by excitation and emission filters, beamsplitters, and polarizers. The G factor was calculated for each experiment by using the basal polarization value determined with the BOCILLIN FL-only wells.
RESULTS AND DISCUSSION
Sensitivity of BOCILLIN FL for the detection of purified PBP2x proteins of S. pneumoniae. To assess the sensitivity of BOCILLIN FL, a derivative of penicillin V (Fig. 1) , for the detection of PBPs, we performed fluorescent BOCILLIN FL and 125 I-labeled penicillin V binding experiments with purified penicillin-sensitive and -resistant PBP2x proteins. When the PBP2x proteins were labeled with 125 I-labeled penicillin V, 7.5 to 15 ng of the purified PBP2x proteins was detectable after overnight exposure of the gels (data not shown). When both proteins were labeled with BOCILLIN FL, 30 to 60 ng of the proteins was detectable with the naked eye under UV light (data not shown). The sensitivity of this reagent for detection of PBPs is similar to that observed with fluorescein-labeled compounds (8) . With the aid of a FluorImager, 2 to 4 ng of the penicillin-sensitive PBP2x protein was clearly detected when labeled with BOCILLIN FL (Fig. 2A) . A linear increase in the fluorescence intensity of the enzyme was observed when the amount of the enzyme increased (Fig. 2B) . Thus, these results suggest that the BOCILLIN FL method is at least as sensitive as the 125 I-labeled penicillin V method.
Detection of PBPs in bacterial cell membrane preparations.
To further evaluate the utility of BOCILLIN FL for the detection of PBPs, we carried out fluorescent BOCILLIN FL binding assays with the membrane preparations of E. coli, P. aeruginosa, and S. pneumoniae. As shown in Fig. 3 , PBPs from these organisms were clearly detected when labeled with BOCILLIN FL, and their profiles are very similar to those reported previously with 3 H-, 14 C-, or 125 I-labeled penicillin used as a labeling reagent (14, 21, 22, (26) (27) (28) 32) . Using a mini-gel (SDS-PAGE) system, we were unable to separate the S. pneumoniae PBP1a protein from its PBP1b protein (Fig. 3,  lane 1) .
As shown in Fig. 4 , the intensities of most PBP bands, except PBP4, increased when the E. coli membrane preparation was labeled with BOCILLIN FL concentrations ranging from 1.6 to 25 M. When concentrations of BOCILLIN FL were lower than 0.8 M, BOCILLIN FL failed to clearly detect PBPs (data not shown). At concentrations of BOCILLIN FL of 25 M or higher, the E. coli PBPs appeared to be saturated (data not shown). Thus, we conclude that 1.6 M BOCILLIN FL is minimal for routine labeling experiments for E. coli.
Comparison of the penicillin-sensitive and -resistant PBP2x proteins of S. pneumoniae (hex) R6 and 328, respectively, by fluorescent BOCILLIN FL binding assays. To further examine the utility of BOCILLIN FL for routine comparisons of PBPs for their affinities for ␤-lactams, we labeled both purified PBP2x proteins with BOCILLIN FL and determined their IC 50 s for penicillin G. As shown in Fig. 5 , the IC 50 s of the penicillin-sensitive and -resistant PBP2x proteins for penicillin G were determined to be 22 and 312 M, respectively. Previously, the K d values of the penicillin-sensitive and -resistant PBP2x proteins for penicillin V were determined to be 0.11 and 1.28 M, respectively (33) . The affinities of the two PBP2x proteins for BOCILLIN FL have not been determined and may be different. Nevertheless, these results are consistent with our previous finding that the affinity of the penicillin-sensitive PBP2x protein for 125 I-labeled penicillin V is about 12-fold higher than that of the penicillin-resistant PBP2x protein (33) .
We also employed fluorescence polarization technology to compare the affinities of the penicillin-sensitive PBP2x protein for penicillin G and other ␤-lactam antibiotics. As shown in Fig. 6 , the IC 50 of the penicillin-sensitive PBP2x protein for penicillin G was determined to be 7.9 nM. The IC 50 s of the PBP2x protein for cefotaxime, imipenem, piperacillin, methicillin, cefaclor, and cephalexin were determined to be 4.4, 5.1, 17, 59, 294, and 1,627 nM, respectively. The k 2 /K value or acylation efficiency of BOCILLIN FL for PBP2x can be derived (7a, 13) from the k 2 /K value of penicillin G for the penicillin-sensitive PBP2x protein of S. pneumoniae, which is known to be 58,000 M Ϫ1 s Ϫ1 (17, 18) . Assuming the IC 50 of the penicillin-sensitive PBP2x enzyme for penicillin G is 22 M, as determined by the gel-based assay (Fig. 5B) , the k 2 /K value of BOCILLIN FL for this PBP2x is estimated to be 128,000 M Ϫ1 s
Ϫ1
. If the IC 50 of the PBP2x enzyme for penicillin G is 7.9 nM as determined by fluorescence polarization assay (Fig. 6) , the k 2 /K value for the enzyme is approximately 232,000 M Ϫ1 s
. Thus, with the IC 50 determined either by gel-based assay or fluorescence polarization method, a similar k 2 /K value for BOCILLIN FL was derived. On the basis of these two derived k 2 /K values of BOCILLIN FL for the PBP2x enzyme, the following k 2 /K values can be derived for these antibiotics from their IC 50 s as follows (12, 13) : 58,000 to 128,000, 51,000 to 102,000, 15,000 to 27,000, 4,000 to 8,000, and 160 to 300 M Ϫ1 s Ϫ1 for cefotaxime, imipenem, piperacillin, methicillin, and cephalexin, respectively. The k 2 /K values of these antibiotics for the PBP2x enzyme were previously reported to be 162,000, 107,000, 53,000, 4,900, and 1,600 M Ϫ1 s
, respectively (17, 18) . Thus, our k 2 /K values are in agreement with those reported (17, 18) , except that our k 2 /K value for cephalexin was significantly lower. Nevertheless, cephalexin had the lowest k 2 /K value in both cases (17, 18 ; this study).
The IC 50 of the penicillin-sensitive PBP2x protein for penicillin G determined by the gel-based assay (22 M) was about 3,000 times higher than that determined by the fluorescence polarization assay (7.9 nM). This difference is not surprising, since the concentration of BOCILLIN FL (labeling reagent) used in the gel-based assay (10 M) was 5,000 times higher than the concentration used in the fluorescence polarization assay (2 nM). When IC 50 s are determined by a true competition assay, the use of higher substrate concentrations generates higher IC 50 s with a fixed amount of enzyme (2, 4, 12) . In addition, the molar ratio of BOCILLIN FL to the enzyme for the gel-based assay (5 Ϸ 10 M BOCILLIN/FL/2 M PBP2x) was approximately three times higher than that for the fluorescence polarization assay (1.5 Ϸ 2 nM BOCILLIN FL/1.3 nM PBP2x). The concentration of the enzyme used in the gel-based assay (2 M Ϸ 3 g in 20 l) was approximately 1,500 times higher than that used in the fluorescence polarization assays (1.3 nM). Despite the very different conditions employed in the two types of assays (gel-based and fluorescence polarization assays), especially the different concentrations of BOCILLIN FL used in the two assays, the derived k 2 /K values for BOCILLIN FL were in excellent agreement (see above). Together, these results suggest that BOCILLIN FL can be used to evaluate relative affinities of PBPs for ␤-lactam antibiotics.
Finally, the standard assay conditions for the determination of IC 50 s for ␤-lactam antibiotics include prelabeling enzymes with ␤-lactam compounds to be tested, followed by incubation with a labeled ␤-lactam compound (3, 28) . In this study, the IC 50 s were determined by a true competition assay and were thus strictly dependent on the BOCILLIN FL concentrations utilized in the assay (12) .
Implications and conclusions. In this study, we describe a new, rapid, and sensitive method for the detection and study of PBPs. We used this method to detect PBPs from membrane preparations of three different organisms and to compare two penicillin-sensitive and -resistant PBP2x proteins for their relative affinities for penicillin G. The PBP profiles generated by this method are very similar to those reported before by the method of 3 H-, 14 C-, or 125 I-labeled penicillin (14, 21, 22, (26) (27) (28) 32) . Using this method, we were also able to demonstrate that a PBP1a mutant of S. pneumoniae was indeed missing the PBP1a protein compared with its parent strain (data not shown). The IC 50 s determined for the penicillinsensitive and -resistant PBP2x proteins allowed us to directly evaluate their relative affinities for penicillin G and other ␤-lactam antibiotics. The results of this comparative study are consistent with those of the previous studies with 125 I-and 14 C-labeled penicillin and also a thioester substrate (17, 18, 33) . Finally, this methodology was also successfully applied to the detection of a PBP2x protein during its purification (data not shown). The results of our study, therefore, have validated BOCILLIN FL as a labeling reagent for the detection of PBPs and the evaluation of relative affinities of PBPs for different ␤-lactam antibiotics.
The use of BOCILLIN FL as a labeling reagent for the detection of PBPs offers several advantages over the radioisotope methods (22, 27, 28) . By this method, results can be obtained immediately after the completion of SDS-PAGE, since no gel manipulations are required for detection. Routinely, the 125 I-labeled penicillin V and 3 H-or 14 C-labeled penicillin methods require days to weeks. This BOCILLIN FL method is sensitive, allowing rapid detection of quantities of proteins in nanograms with the naked eye under UV light or with the aid of a FluorImager. The sensitivity of this method is similar to that of the 125 I-labeled penicillin V method, which also detected quantities of the proteins as small as nanograms but required overnight exposure. The BOCILLIN FL method does not involve the use of radioactive materials, in contrast to the 3 H-, 14 C-, and 125 I-labeled penicillin methods. Thus, no hazardous materials are produced. Only small amounts of BO-CILLIN FL are needed for routine labeling studies. We established that a concentration as low as 1.6 M the reagent could be used for labeling bacterial membrane preparations. BOCILLIN FL and 3 H-labeled penicillin are both commercially available (28) , but the latter methodology typically requires weeks for the development of PBP bands.
125 I-labeled penicillin V has considerably shortened the amount of time that is required, but it is not commercially available (27) . Fluorescein-labeled and biotinylated penicillins offer similar advantages (5, 8, 15, 20) , yet they are not commercially available (5, 8, 15, 20) . Also, the use of biotinylated penicillins requires transferring proteins to membranes and blocking and developing the membranes, processes which usually require at least a full day. BOCILLIN FL is a safe and sensitive reagent for the detection and study of bacterial PBPs.
Finally, a comparison of the PBP binding properties of BO-CILLIN FL and those of its parent molecule, penicillin V, has not yet been carried out. Therefore, the effects of the addition of the fluorophore on the PBP binding properties of BOCIL-LIN FL are unknown. Further study is also needed to address the suitability of BOCILLIN FL for kinetic studies of PBPs. 
